Plasma Concentration Studies
Cagrilintide
NN9838
CAS: 1415456-99-3
ZP8396
A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management. Premium Research Peptide.
99%+ Purity
Purity Tested
Research Use Only
Laboratory Use
Peptide Profile
Peptide Type
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Compound Information
Technical specifications
What Is Cagrilintide?
Stability Information
Protect from light. Avoid repeated freeze-thaw. Blue color indicates copper binding.
Lyophilized (powder)
Store at -20°C long-term
Reconstituted
2-8°C • use within days
Light protection
Protect from light
Sources & References
Peer-reviewed research
New England Journal of Medicine
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 • DOI: 10.1056/NEJMoa2502081
Garvey WT, Blüher M, Osorto Contrera...
- View Source
The Lancet
Once-weekly cagrilintide for weight management in people with overweight and obesity: a...
2021 • PMID: 34798060
Lau DCW et al.
- View Source
The Lancet
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of...
2021 • PMID: 33894838
Enebo LB et al.
- View Source
Nature Communications
Structural and dynamic features of cagrilintide binding to calcitonin-family receptors
2025
- View Source
Journal of Medicinal Chemistry
Development of Cagrilintide, a Long-Acting Amylin Analogue
2021
- View Source
Cardiology in Review
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
2024 • DOI: 10.1097/CRD.0...
PMID: 36883831
D'Ascanio AM, Mullally JA, Frishman...
- View Source
